Trigemina, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2006-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.trigemina.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)TI-001 (Intranasal Oxytocin) for Treatment of High Frequency Episodic Migraine and Chronic Migraine
Phase 2
Completed
- Conditions
- High Frequency Episodic Migraine and Chronic Migraine
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-04-24
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- Trigemina, Inc
- Target Recruit Count
- 240
- Registration Number
- NCT01839149
News
No news found